(Q39445257)

12 September 2017

1 reference

title

Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients (English)

1 reference

12 September 2017

0 references

1 reference

Kahan BD

1

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

Transplantation Proceedings

12 September 2017

published in

1 reference

12 September 2017

volume

30

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

2185-2188

1 reference

Sirolimus: a new agent for clinical renal transplantation

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900585-5

7 January 2021

Case report--sirolimus rescue therapy for refractory renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900585-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900585-5

1 reference

7 January 2021

Cyclosporine: a powerful addition to the immunosuppressive armamentarium

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900585-5

7 January 2021

The impact of steady-state cyclosporine concentrations on renal allograft outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900585-5

7 January 2021

Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900585-5

7 January 2021

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900585-5

7 January 2021

Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900585-5

7 January 2021

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900585-5

7 January 2021

Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900585-5

7 January 2021

The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900585-5

7 January 2021

Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900585-5

7 January 2021

10.1016/S0041-1345(98)00585-5

Identifiers

DOI

1 reference

12 September 2017

1 reference